Presentation is loading. Please wait.

Presentation is loading. Please wait.

EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery.

Similar presentations


Presentation on theme: "EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery."— Presentation transcript:

1 EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery  J. Holm, M. Vidlund, F. Vanky, Ö. Friberg, E. Håkanson, S. Walther, R. Svedjeholm  British Journal of Anaesthesia  Volume 113, Issue 1, Pages (July 2014) DOI: /bja/aeu088 Copyright © 2014 The Author(s) Terms and Conditions

2 Fig 1 Flow chart of study design and stratification.
British Journal of Anaesthesia  , 75-82DOI: ( /bja/aeu088) Copyright © 2014 The Author(s) Terms and Conditions

3 Fig 2 ROC analysis to evaluate the discrimination of the combined model of EuroSCORE II and preoperative NT-proBNP (as a continuous variable) with regard to severe circulatory failure after operation. British Journal of Anaesthesia  , 75-82DOI: ( /bja/aeu088) Copyright © 2014 The Author(s) Terms and Conditions

4 Fig 3 Cumulative freedom from cardiac death (Kaplan–Meier) related to preoperative NT-proBNP in patients undergoing isolated CABG for ACS (n=363). British Journal of Anaesthesia  , 75-82DOI: ( /bja/aeu088) Copyright © 2014 The Author(s) Terms and Conditions


Download ppt "EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery."

Similar presentations


Ads by Google